Regulatory protein:
OGT S306-p
PLK1 S385-p
PRP4 S66-p , T74-p
TBK1 T74-p , S184-p , S306-p , S385-p
Treatment:
anti-CD3 S66-p , S67-p , T74-p , T154-p , T160-p
AZD1152 S378-p
BI2536 S250-p , S378-p , S385-p
BI_4834 S66-p , S67-p , S79-p , T208-p , S378-p
dasatinib S66-p , S67-p , T74-p
EGF S66-p , S67-p , T137-p , S156-p , T208-p
FGF7 Y351-p
ischemia S66-p , T208-p , S385-p
lapatinib T74-p
LRRK2-IN-1 T74-p , S306-p
MEK_inhibitor_I S66-p , S67-p
metastatic potential S66-p , S67-p , S306-p
MG132 K389-ub , K393-ub
MG132_withdrawal T208-p
MLN8054 S306-p , S315-p , S385-p
nocodazole S59-p , T74-p , S156-p , T160-p , T208-p , S306-p , T312-p , S315-p , S378-p
rapamycin S66-p , S67-p
selumetinib S156-p , S158-p
U0126 S156-p
vemurafenib S156-p
ZM447439 S378-p